Abstract
Membrane transporters are key players in the regulation of homeostasis, cell integrity
and metabolism in organisms. The ATP-binding cassette (ABC) efflux transporters
and Organic Anion-transporting Polypeptide (OATP) influx transporters are two main
superfamilies that are expressed in pharmacologically important organs such as the
liver, small intestine, kidney and the blood-brain barrier (BBB). These transporters
can transport endogenous and exogenous molecules and thereby are important in
the absorption, disposition, elimination and toxicity of many drugs. In this thesis we
delved deeper into the pharmacological functions of ABCB1 and ABCG2 in vitro and in
vivo for several anti-cancer drugs using specialized cell lines and various knockout and
transgenic mouse models. We additionally looked into the pharmacological impact of
CYP3A proteins which form one of the main metabolic enzyme complexes. We used
various knockout and humanized mouse models to study its effects on a subset of anticancer
drugs.
The studies presented in this thesis contribute to our current knowledge on
ABC efflux transporters and CYP3A metabolizing enzymes. We demonstrated the role
ABCB1 and ABCG2 play in restricting brain accumulation of the TKIs afatinib, osimertinib,
ibrutinib and ponatinib by means of in vitro and in vivo experiments. We also found that
while these two ABC transporters impact the oral bioavailability of afatinib, that this is
not the case for the other three TKIs, whose oral bioavailability is restricted mainly due
to the metabolizing Cytochrome P450 enzymes. Our studies illustrate the continued
importance of using mouse models to study the transport proteins in vivo, thereby
enhancing our understanding of their functions. Taking everything together, we believe
there is still much to be discovered in the field of transporter proteins as well as the
metabolizing enzymes, in terms of their pharmacological, but also their physiological
functions.
Original language | English |
---|---|
Qualification | Doctor of Philosophy |
Awarding Institution |
|
Supervisors/Advisors |
|
Award date | 25 Sept 2019 |
Publisher | |
Print ISBNs | 978-94-6375-554-2 |
Publication status | Published - 25 Sept 2019 |
Keywords
- ABC transporters
- ABCB1
- ABCG2
- Cytochrome P450
- afatinib
- osimertinib
- ibrutinib
- ponatinib
- anti-cancer therapies
- pharmacokinetics
- BBB
- bioavailability